Greg Ball
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Statistical Methods in Clinical Trials 15
- Toxicology 10
- Pharmacovigilance and Adverse Drug Reactions 10
- Co-authors
- Francesco Onida (5 shared papers)Hagop M. Kantarjian (5 shared papers)Michael J. Keating (4 shared papers)Miloslav Beran (2 shared papers)Armand B. Glassman (2 shared papers)Terry L. Smith (2 shared papers)Maher X. Albitar (2 shared papers)Elihu H. Estey (2 shared papers)
- Journals
- Therapeutic Innovation & Regulatory Science (10 papers)Contemporary Clinical Trials (7 papers)Blood (3 papers)Pharmaceutical Statistics (2 papers)American Journal of Clinical Pathology (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Greg Ball
32 papers receiving 897 citations
Peers
Comparison fields: 5 of 59
- Hematology 423
- Toxicology 71
- Genetics 111
- Statistics and Probability 89
- Endocrinology, Diabetes and Metabolism 71
Countries citing papers authored by Greg Ball
This map shows the geographic impact of Greg Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Ball more than expected).
Fields of papers citing papers by Greg Ball
This network shows the impact of papers produced by Greg Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Ball. The network helps show where Greg Ball may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Ball, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 317 | |
| 2 | 2015 | 94 | |
| 3 | 2012 | 77 | |
| 4 | 2002 | 75 | |
| 5 | The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate. | 2003 | 63 |
| 6 | 2008 | 48 | |
| 7 | 2016 | 33 | |
| 8 | 2003 | 32 | |
| 9 | 2016 | 27 | |
| 10 | 2016 | 18 | |
| 11 | 2011 | 15 | |
| 12 | 2011 | 13 | |
| 13 | 2021 | 13 | |
| 14 | 2002 | 11 | |
| 15 | 2011 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2004 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2020 | 7 |
About Greg Ball
Greg Ball is a scholar working on Statistics and Probability, Toxicology, Hematology, Sensory Systems and Nephrology, having authored 33 papers that have together received 931 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (15 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Pharmaceutical studies and practices (1 paper), Acute Kidney Injury Research (1 paper), Radiation Dose and Imaging (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Hematology (423 citations), Toxicology (71 citations), Genetics (111 citations), Statistics and Probability (89 citations) and Endocrinology, Diabetes and Metabolism (71 citations). Greg Ball has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Francesco Onida, Hagop M. Kantarjian, Michael J. Keating, Miloslav Beran, Armand B. Glassman, Terry L. Smith, Maher X. Albitar, Elihu H. Estey, Monica I. Kwari and Patrick Schnell. Their work appears in journals such as Therapeutic Innovation & Regulatory Science, Contemporary Clinical Trials, Blood, Pharmaceutical Statistics and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.